Informazioni sul prodotto
Ibrutinib is an inhibitor of tyrosine kinases, including BTK, ABL1, and PDGFR. It is a racemic mixture of ibrutinib enantiomers that has been shown to be effective against lymphocytic leukemia. Ibrutinib has minimal toxicity in humans and has been shown to be well-tolerated with few side effects. Ibrutinib binds to the active site of BTK, blocking the attachment of ATP and leading to inhibition of downstream signaling pathways that are involved in cell proliferation and survival. The drug also inhibits the activity of other tyrosine kinases such as ABL1 and PDGFR.
Proprietà chimiche
Richiesta tecnica su: 3D-LMB56387 Ibrutinib Racemate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
